Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeted gene silencing in vivo by platelet membrane–coated metal-organic framework nanoparticles

Science Advances(2020)10.1126/sciadv.aaz6108Source: DataRank Database

Targeted gene silencing in vivo by platelet membrane–coated metal-organic framework nanoparticles is a research paper published in Science Advances (2020). On theSindex it has a DataRank of 0. It has been cited 358 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access358 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 15.28)OA: goldTopics (71)Linked Datasets (10)DataCite Reuse (10)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Hua Gong ORCID,Jiarong Zhou ORCID,Qiangzhe Zhang ORCID,Weiwei Gao ORCID,Ronnie H. Fang ORCID

Live enrichment

PubMed:32258408 PMC:PMC7101224 OpenAlex:https://openalex.org/W3013635432

National Institutes of Health

Grant: R01CA200574

NCI NIH HHS

Grant: T32 CA153915

National Institutes of Health

Grant: 5R01CA200574-04

Tumor-Targeted Chemo-Immunotherapy for Osteosarcoma Metastasis

National Institutes of Health

Grant: 5T32CA153915-10

Cancer Researchers in Nanotechnology (CRIN)

FWCI

15.28

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by-nc

journalhttps://www.science.org/doi/pdf/10.1126/sciadv.aaz6108?download=true

publisherhttps://www.science.org/doi/pdf/10.1126/sciadv.aaz6108?download=true

publisherhttps://www.science.org/doi/pdf/10.1126/sciadv.aaz6108

journalhttps://doi.org/10.1126/sciadv.aaz6108

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32258408

Fields of Study

RNA Interference and Gene DeliveryAdvanced biosensing and bioanalysis techniquesMicroRNA in disease regulation0301 basic medicine02 engineering and technology03 medical and health sciences0210 nano-technology

MeSH Terms

Metal-Organic FrameworksSurvivinAnimalsBlood PlateletsCell MembraneDrug CarriersHumansGenes, ReporterGene Transfer TechniquesCoated VesiclesGene SilencingXenograft Model Antitumor AssaysRNA, Small InterferingCell Line, TumorMiceMetal NanoparticlesGene Knockdown Techniques

Keywords

Gene silencingSmall interfering RNAIn vivoNanoparticlePlateletMembraneChemistryGene deliveryRNANanotechnologyGenetic enhancementCell biologyCancer researchGeneMaterials scienceMedicineBiologyBiochemistryImmunologyBiotechnologyBlood Platelets570SurvivinCoated Vesicles610Metal NanoparticlesBioengineeringSmall InterferingCell LineMiceGenes, ReporterCell Line, TumorGeneticsAnimalsHumansRNA, Small InterferingReporterResearch ArticlesMetal-Organic FrameworksDrug CarriersTumorCell MembraneGene Transfer TechniquesGene TherapyXenograft Model Antitumor AssaysGenesGene Knockdown Techniques

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of Enhancement of antitumor immunotherapy using mitochondria-targeted cancer cell membrane-biomimetic MOF-mediated sonodynamic therapy and checkpoint blockade immunotherapy

10.6084/m9.figshare.19767809.v1figshare

Additional file 1 of Enhancement of antitumor immunotherapy using mitochondria-targeted cancer cell membrane-biomimetic MOF-mediated sonodynamic therapy and checkpoint blockade immunotherapy

10.6084/m9.figshare.19767809figshare

Additional file 1 of Reprogramming mitochondrial metabolism of macrophages by miRNA-released microporous coatings to prevent peri-implantitis

10.6084/m9.figshare.24849017.v1figshare

Additional file 1 of Reprogramming mitochondrial metabolism of macrophages by miRNA-released microporous coatings to prevent peri-implantitis

10.6084/m9.figshare.24849017figshare

Additional file 2 of Reprogramming mitochondrial metabolism of macrophages by miRNA-released microporous coatings to prevent peri-implantitis

10.6084/m9.figshare.24849067.v1figshare

Additional file 2 of Reprogramming mitochondrial metabolism of macrophages by miRNA-released microporous coatings to prevent peri-implantitis

10.6084/m9.figshare.24849067figshare

Additional file 1 of Photosensitive and dual-targeted chromium nanoparticle delivering small interfering RNA YTHDF1 for molecular-targeted immunotherapy in liver cancer

10.6084/m9.figshare.26736441.v1figshare

Additional file 1 of Photosensitive and dual-targeted chromium nanoparticle delivering small interfering RNA YTHDF1 for molecular-targeted immunotherapy in liver cancer

10.6084/m9.figshare.26736441figshare

Additional file 2 of Photosensitive and dual-targeted chromium nanoparticle delivering small interfering RNA YTHDF1 for molecular-targeted immunotherapy in liver cancer

10.6084/m9.figshare.26736444figshare

Additional file 2 of Photosensitive and dual-targeted chromium nanoparticle delivering small interfering RNA YTHDF1 for molecular-targeted immunotherapy in liver cancer

10.6084/m9.figshare.26736444.v1figshare